TYR and melanoma: Additionally, small interfering RNA-mediated MITF silencing in melanoma cells significantly reduced melanin content by inhibiting tyrosinase, TRP-1, and MC1R [35], indicating that inhibition of the transcriptional activation of MITF is also a promising strategy to treat hypermelanogenic disorders.